Katy Milne Selected Research

NS 11

10/2021

Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katy Milne Research Topics

Disease

26	Neoplasms (Cancer) 12/2021 - 07/2007
10	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 12/2007
3	Carcinoma (Carcinomatosis) 01/2021 - 05/2012
3	Ascites 05/2012 - 01/2008
3	Breast Neoplasms (Breast Cancer) 01/2011 - 06/2010
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
2	Testicular Neoplasms (Testicular Cancer) 01/2018 - 01/2016
1	Chordoma 12/2021
1	Triple Negative Breast Neoplasms 12/2021
1	Sclerosis 10/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Carcinogenesis 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2020
1	Rhabdoid Tumor (Rhabdoid Tumors) 11/2019
1	Endometrial Neoplasms (Endometrial Cancer) 04/2019
1	Cytokine Release Syndrome 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Adenocarcinoma 09/2017
1	Adenocarcinoma of Lung 09/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2016
1	Confusion (Bewilderment) 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2015
1	Pathologic Complete Response 01/2011

Drug/Important Bio-Agent (IBA)

7	AntigensIBA 01/2021 - 07/2007
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 12/2007
4	Biomarkers (Surrogate Marker)IBA 09/2017 - 01/2011
3	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2020
3	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2018
3	LigandsIBA 01/2020 - 06/2015
3	Neoplasm Antigens (Tumor Antigens)IBA 08/2015 - 01/2008
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 11/2019
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2014
2	PlatinumIBA 02/2017 - 05/2012
2	Granzymes (Granzyme)IBA 07/2009 - 01/2008
1	Brachyury protein (Brachyury)IBA 12/2021
1	NivolumabIBA 12/2021
1	Small Cytoplasmic RNAIBA 10/2021
1	NS 11IBA 10/2021
1	SuspensionsIBA 10/2021
1	MesothelinIBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	CarcinogensIBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	avelumabIBA 01/2021
1	Folate Receptor 1IBA 01/2021
1	ChemokinesIBA 12/2020
1	IpilimumabIBA 06/2020
1	Complex MixturesIBA 01/2019
1	Retinoblastoma ProteinIBA 01/2018
1	CytokinesIBA 01/2018
1	TAC AlternateIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 02/2017
1	taxaneIBA 02/2017
1	B7-H1 AntigenIBA 01/2016
1	Differentiation AntigensIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	HLA-DR Antigens (HLA-DR)IBA 08/2015
1	MHC class II transactivator proteinIBA 06/2015
1	ParaffinIBA 06/2015
1	Formaldehyde (Formol)FDA Link 06/2015
1	Hydroxysteroid DehydrogenasesIBA 03/2014
1	Estrogen ReceptorsIBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	AnthracyclinesIBA 01/2011
1	Estrogen Receptor alphaIBA 01/2011
1	integrin beta7IBA 09/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2010
1	IntegrinsIBA 09/2010
1	OvalbuminIBA 11/2009
1	Immunoglobulin G (IgG)IBA 01/2008
1	AutoantibodiesIBA 01/2008
1	EpitopesIBA 12/2007
1	InterleukinsIBA 12/2007

Therapy/Procedure

9	Immunotherapy 12/2021 - 07/2007
4	Therapeutics 12/2020 - 01/2011
3	Drug Therapy (Chemotherapy) 12/2021 - 01/2011
3	Neoadjuvant Therapy 02/2017 - 01/2011
2	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2020 - 01/2018
1	Oncolytic Virotherapy 12/2021